Global Human Rotavirus Vaccine Market – Key Players
Key players profiled in the report are:
- Bharat Biotech
- Merck & Co. Inc.
- GlaxoSmithKline plc
Global Human Rotavirus Vaccine Market – Regional Analysis
The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new technology in the US drives the global human rotavirus vaccine market. Also, concentration of major research companies and vaccine research sector in the developed countries of this region is adding fuel to the market growth.
Click to Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4171 .
Europe is the second largest market in the world due to high income and healthcare penetration.
Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.
Global Human Rotavirus Vaccine Market – Overview
Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Rotavirus vaccine is administered by mouth and requires two or three doses which are given starting around six weeks of age. The vaccine first became available in the United States in 2006. Rotavirus is a double-stranded RNA virus of the family Reoviridae and is transmitted by the faecal-oral route. It infects the cell lining of the small intestine and causes gastroenteritis. The Global Human Rotavirus Vaccine Market is expected to reach US$ 12.3 billion by 2023, and the market is projected to grow at a CAGR of ~ 11.2 % during the forecast period 2017-2023
Global Human Rotavirus Vaccine Market – Competitive Analysis
There are majorly three pharmaceutical companies licensed for rotavirus vaccines, Rotarix that is manufactured by GlaxoSmithKline Biologicals and RotaTeq manufactured by Merck & Co. Inc., a U.S. based company challenging these two major companies an Indian pharmaceutical company Bharat Biotech launched the lowest price rotavirus vaccine named Rotavac. There are various companies are seeking interest in manufacturing of these vaccine due low presence of manufacturers. New necessities for the development, manufacturing and licensure of new vaccine candidates have caused a marked rise in manufacturers’ investment costs. To compensate these investments in research and development and engender profits while the manufacturer monopolizes the market.
The company GlaxoSmithKline has offered to deliver this vaccine at price of US$ 2.50 every dose, which creates a 67% decrease over the lowest public price now available. Merck & Co. Inc. has offered to deliver the vaccine at price of US$ 3.5 every dose once the volume of purchase reaches 30 million doses. Although in 2011 there Indian company Bharat Biotech, announced the cost of its vaccine challenging GSK, Merck in the market. With its product Rotavac vaccine, the company quoted the lowest price i.e. 60 rupees that is less than 1$ for three doses of rotavirus vaccine.
The successful launch of this products by Bharat Biotech brought an end to the products research and development since 1985. The company with the help of various institutes like PATH, NIH, CDC and the Stanford University School of Medicine made it possible for the successfully launch of the product. In 2015 the company raised a fund of about $20 million for constructing new facilities and supporting infrastructure at its Genome Valley plant. With this development in its infrastructure the company is expected to generate a capacity of 300 million doses every year. Due to this developments the company lead the market in India and gradually across the world.
Global Human Rotavirus Vaccine Market – Segmentation
The global Human rotavirus vaccine market has been segmented on the basis of type and end users.
Based on type, the market has been segmented as Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb and others.
Based on the end users, the market has been segmented as hospitals & clinics, academic and research and others.
Major Table of Contents
1.2 Scope of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.3 Market Structure
- Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
- Market Dynamics
3.4 Macroeconomic Indicators
- Market Factor Analysis
Regarding Any Customization on this Report, Ask to an Expert @ https://www.marketresearchfuture.com/enquiry/4171 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312